|Bid||0.0000 x 800|
|Ask||0.0000 x 1800|
|Day's Range||1.7000 - 1.7800|
|52 Week Range||1.5600 - 6.6000|
|Beta (5Y Monthly)||1.66|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 03, 2021 - Nov 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||3.50|
YARDLEY, Pa. & EL SEGUNDO, Calif., September 08, 2021--NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced a collaboration with Intraprise Health, the provider of HIPAA One Security and Privacy Compliance software. HIPAA One’s Security Risk Assessment software will now be available to the growing network of healthcare provider offices utilizing NantHealth’s NaviNet® solution, offering a comprehens
Welcome, everyone, and thank you for joining us today to discuss NantHealth's 2021 second-quarter financial results. On the call today are Ron Louks, chief operating officer; and Bob Petrou, our chief financial officer.
NantHealth, Inc. (NH) delivered earnings and revenue surprises of 20.00% and -5.35%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?